RPAM
EIGR

Rhenman & Partners Asset Management’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

Rhenman & Partners Asset Management’s Portfolio EIGR Stock Details EIGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-267
Closed -$2.27M – 101
2015
Q1 		$2.27M Sell
267
-169
-39% -$1.44M 0.38% 81
2014
Q4 		$3.83M Sell
436
-134
-24% -$1.18M 1.11% 30
2014
Q3 		$2.68M Buy
570
+468
+459% +$2.2M 0.79% 46
2014
Q2 		$737K Buy
+102
New +$737K 0.22% 90